Medmain
Healthcare Software · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
104,2-4-5 Akasaka Chuo-ku, Akasaka, Fuku...Website
www.medmain.comRevenue
<$5 MillionIndustry
About Medmain
Medmain Org Chart
Is Medmain your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Medmain has new funding data
Website visits: Recent activity has been detected on your website
Check if Medmain has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Medmain
Click to see if Medmain had a recent Job posting/layoffs
Product Launch: Get notified when Medmain launches new products
Check out if Medmain is spiking on competitors!
Earning: See what the market has to say on Medmain recently announced quarterly report
Medmain, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Medmain as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Medmain is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Medmain is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Medmain.
Medmain financials insights
Gather financial insights about Medmain, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$3.3M
Medmain Tech Stack
A closer look at the technologies used by Medmain
Medmain News & Media
Medmain, a Japanese pathology AI startup, has raised 3.3M USD (total 18M USD), with investments from One Capital, Niremia Collective, and Plug and Play
FUKUOKA, Japan, May 8, 2025 /PRNewswire/ -- Medmain Inc., a Japanese medtech startup that offers PidPort, an AI-powered cloud system to assist in digital pathology, is pleased to announce that it has raised 3.3 million USD through a third-party allotment of shares, with One Capital as the lead investor and Niremia Collective and Plug and Play as additional participants. With this round, the company's total equity funding has reached 18 million USD. Medmain has rasedMedmain Inc. Has Been Selected for the U.S. Market Gateway Accelerator for BioSciences and MedTech
FUKUOKA, Japan, Sept. 12, 2023 /PRNewswire/ -- Medmain Inc. (https://en.medmain.com), a Japanese medtech startup that offers PidPort, an AI-powered cloud system to assist in digital pathology, is pleased to announce that it has been selected for the "U.S. Market Gateway Accelerator for BioSciences and MedTech", an acceleration program sponsored by WorldUpstart, LLC. We will take advantage of this opportunity to move forward with our business development in the U.S. Medmain Inc. The "U.S. Market
Top Healthcare Software Companies
Frequently Asked Questions Regarding Medmain
Medmain Inc. specializes in developing and operating medical technology solutions, particularly focusing on deep learning and AI applications. Their key products include PidPort, an AI-driven system for analyzing pathology images, and Medteria, a cloud service designed for medical students. The company aims to support healthcare professionals world... Read More